Abstract:Angiogenesis is one of the most essential events during embryonic development. The previous studies proved that MEKK3 (MAP3K3) is critical for angiogenesis. However, precisely how MEKK3 regulates the vascular development remains largely unknown. To investigate the impact of MEKK3 in vascular development in vivo and its role in normal physiological and pathological settings, we generated VE-Cadherin CreERT2;MEKK3 flox/+ (control) and VE-Cadherin CreERT2;MEKK3 flox/- (MEKK3 iEC -/-) mice. MEKK3 deletion was induced from postnatal day (P) 1 by administration of tamoxifen daily. The retinal angiogenesis model was used to analyze the blood vessel development in P7 and P12 mice. Whole-mount staining of P7 retinas in MEKK3 iEC -/- mutants showed a significant decrease in vascularized area and branch formation. In contrast, control pups, although only having one copy of the MEKK3 gene in endothelial cells, developed a complete vascular sheet at the same dose of tamoxifen, as did the untreated pups. At P12, MEKK3 iEC -/- mice showed defects in vessel remodeling and arterial patterning. These retinas had dilated and tortuous arteries losing the identical marker. This phenotype accorded with the pathology of AVM (arteriovenous malformation). We then cultured murine aortic rings in 3D matrigel and induced sprouting with VEGF. Administration of TGF-b receptor kinase inhibitor SB431542 to the MEKK3 iEC-/- aorta showed a partial rescue effect on the number of sprouts and vascularized area. It implicated that the vascular malformation in the MEKK3 iEC-/- mice was partially due to the elevated TGF-b signals in endothelial cells. We confirmed the result by staining the retinas with SMA and N-cadherin, which are the downstream genes in TGF-b pathway. It turned out that both SMA and N-cadherin were expressed stronger in MEKK3 iEC-/- retinas than in the control ones. Next, by in vitro studies, we found that endothelial cell activation by VEGF treatment led to rapid and strong phosphorylation of R-SMADs at the linker regions in the control endothelial cells. Such phosphorylation was severely impaired in the MEKK3 -/- endothelial cells. The same results were found in the activation of ERK1/2 and p38. Inhibition of ERK1/2 but not p38 MAPK in control endothelial cells greatly reduced the VEGF-induced phosphorylation of R-SMADs at their linker regions. Inhibition of both ERK1/2 and p38 did not further reduce the SMAD linker region phosphorylation compared to inhibition of ERK1/2. Thus, we determined ERK1/2 are responsible for the VEGF-induced, MEKK3-dependent phosphorylation of R-SMADs at the linker region. Finally, since Notch pathway is an evolutionarily conserved signaling , which directly affects angiogenesis, we used aortic ring model to test their interaction, and detected the gene expression in endothelial cells. Hey1 and Hey2 were over expressed in MEKK3 -/- endothelial cells. Knockdown of Hey1 and Hey2 could rescue the deficient angiogenesis. Knockdown of RBPJ did not affect MEKK3 mediated angiogenesis or induction of Hey1 and Hey2. The above data supported a model whereby MEKK3-mediated SMAD signaling induces HEY1 and HEY2 independently of canonical Notch activation. Disclosures No relevant conflicts of interest to declare.

Angiotensin-converting Enzyme Inhibitor Promotes Angiogenesis Through Sp1/Sp3-mediated Inhibition of Notch Signaling in Male Mice.

Angiotensin‐converting Enzyme Inhibitor Works As a Scar Formation Inhibitor by Down‐regulating Smad and TGF‐β‐activated Kinase 1 (TAK1) Pathways in Mice

Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice

Endothelial S1pr2 regulates post-ischemic angiogenesis via AKT/eNOS signaling pathway

E-Prostanoid 3 Receptor Mediates Sprouting Angiogenesis Through Suppression of the Protein Kinase A/β-Catenin/Notch Pathway

ASSA13-03-41 Angiotensin II Inhibits Cardiac Angiogenesis Via the Cooperation of P53 and Jagged 1

Endothelial S1pr1 Regulates Pressure Overload‐induced Cardiac Remodelling Through AKT‐eNOS Pathway

AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling

SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.

MEKK3 Regulates Angiogenesis Through Smad Signaling

The Sphingosine-1-Phosphate Receptor S1PR1 Restricts Sprouting Angiogenesis by Regulating the Interplay Between VE-Cadherin and VEGFR2

Abstract 198: Angiotensin II Inhibits Cardiac Angiogenesis Via the Cooperation of P53 and Jagged 1

Caspase‐4/11 is Critical for Angiogenesis by Repressing Notch1 Signalling Via Inhibiting Γ‐secretase Activity

Regulation of P53 by Jagged1 Contributes to Angiotensin II-Induced Impairment of Myocardial Angiogenesis

Inhibition of Endothelial Cell Proliferation by Notch1 Signaling is Mediated by Repressing MAPK and PI3K/Akt Pathways and Requires MAML1

Endothelial G protein stimulatory alpha-subunit is a critical regulator of post-ischemic angiogenesis

Endothelial G protein stimulatory α-subunit is a critical regulator of post-ischemic angiogenesis

SIRT1 Mediates Sphk1/S1P-induced Proliferation and Migration of Endothelial Cells.

Role of Notch Signal in Angiotensin Ii Induced Pulmonary Vascular Remodeling

ASSA13-10-14 Cellular Repressor of E1A-Stimulated Genes Accelerates Endothelial Angiogenesis Via Integrin-Linked Kinase-PINCH-CDC42 Activation

Vascular Endothelial Cell Growth–Activated XBP1 Splicing in Endothelial Cells is Crucial for Angiogenesis